In a strategic move to address springtime skincare concerns, Dongkook Pharmaceutical, led by CEO Song Joon-ho, has introduced its latest product line—'Melaset,' specifically designed for hyperpigmentation management.
The 'Melaset' range comprises three innovative products: Melaset Tonin Creamy Essence, Melaset Tonin Cream, and Melaset Tonin Spot Patch, each providing tiered solutions tailored for both mild and severe melasma treatment.
Leveraging Dongkook's technological prowess, the 'Melaset' line is positioned as a K-Dermatology solution, with availability in the globally recognized Olive Young Central Myeongdong Store and its online marketplace.
The formulations boast a dual-action ingredient—Dual Mela Quinone—as well as other potent compounds such as tranexamic acid and glutathione, effectively targeting dullness and uneven skin tone.
The Melaset Tonin Creamy Essence functions as a daily application, targeting both melasma and dull skin, promoting an even, luminous complexion.
Its hydro-milk texture ensures rapid absorption while offering deep hydration, keeping the skin moisturized throughout the day.
Additionally, the product utilizes a three-step micro-encapsulation technique to enhance the absorption of active ingredients, setting a new benchmark in skincare efficacy.
Next is the Melaset Tonin Cream, formulated for concentrated care of both nascent and chronically developed melasma.
Featuring arbutin—an active whitening agent—and Dongkook's signature ingredient, TECA (Centella Asiatica extract), this cream supports skin tone improvement and calming effects, providing a non-sticky, easily absorbed consistency that adheres seamlessly to the skin.
To complete the regimen, the Melaset Tonin Spot Patch addresses localized hyperpigmentation with a dual function for whitening and wrinkle improvement.
Utilizing advanced hydrocolloid technology, these patches feature an exceptional adhesive capability and a beveled edge design, allowing for natural application on uneven skin surfaces.
The offering includes wide patches for broader areas as well as spot patches for targeted care on specific zones such as cheeks, cheekbones, and other localized areas.
A representative from Dongkook Pharmaceutical emphasized the growing interest in functional and efficacious dermatological cosmetics within the K-beauty market.
"With the season bringing reflections on hyperpigmentation severity and locations, we are proud to introduce the 'Melaset' line as a step-by-step solution that simplifies daily skincare routines.
Our hope is for consumers to enjoy a brighter, more radiant complexion effortlessly," they stated.
This launch not only reinforces Dongkook’s commitment to addressing consumers' evolving skincare needs but also showcases the potential for deeper market penetration within the global beauty landscape, especially among investors and supply chain stakeholders looking for innovative solutions.
As K-Beauty continues to gain traction, the 'Melaset' line may drive significant engagement within both domestic and international marketing channels.
